A

APT Medical Inc
SSE:688617

Watchlist Manager
APT Medical Inc
SSE:688617
Watchlist
Price: 349.23 CNY -6.27% Market Closed
Market Cap: 34B CNY
Have any thoughts about
APT Medical Inc?
Write Note

APT Medical Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

APT Medical Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
A
APT Medical Inc
SSE:688617
Change in Working Capital
-ÂĄ623.6m
CAGR 3-Years
-39%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Change in Working Capital
-ÂĄ2B
CAGR 3-Years
-4%
CAGR 5-Years
-13%
CAGR 10-Years
-18%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Change in Working Capital
-ÂĄ9B
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Change in Working Capital
-ÂĄ901.4m
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Change in Working Capital
-ÂĄ2.9B
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
-21%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Change in Working Capital
-ÂĄ3.2B
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

APT Medical Inc
Glance View

Market Cap
33.7B CNY
Industry
Health Care

APT Medical, Inc. engages in the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 1,511 full-time employees. The company went IPO on 2021-01-07. The firm's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The firm's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The firm is also engaged in related original equipment manufacturer (OEM) business. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
329.82 CNY
Overvaluation 6%
Intrinsic Value
Price
A

See Also

What is APT Medical Inc's Change in Working Capital?
Change in Working Capital
-623.6m CNY

Based on the financial report for Dec 31, 2023, APT Medical Inc's Change in Working Capital amounts to -623.6m CNY.

What is APT Medical Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-38%

Over the last year, the Change in Working Capital growth was -21%. The average annual Change in Working Capital growth rates for APT Medical Inc have been -39% over the past three years , -38% over the past five years .

Back to Top